engleski

World Congress of Biological Psychiatry, 8th, Vienna, Austria, June 28- July 3, 2005 (Part I & II)

The 8th World Congress of Biological Psychiatry intended to cover the latest scientific data in biological psychiatry. However, the breakthroughs were not presented at the Congress, and surprisingly few new data were presented during the sections the authors of this report were able to follow. Only a few new indications of the known drugs were discussed, such as the use of atypical antipsychotics in the treatment of depression and mood disorders.

neuropeptides; escitalopram; SB-649915-B a novel 5-HT1 autoreceptor antagonist; ZK808762; Hypericum perforatum; Ispronicline (TC-1734); ND7001

nije evidentirano